The need for additional metrics to assess therapeutic equivalence of some multiphasic modified-release products.
Kondra, Peter M
The need for additional metrics to assess therapeutic equivalence of some multiphasic modified-release products. [electronic resource] - Clinical therapeutics Sep 2011 - 1214-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1879-114X
10.1016/j.clinthera.2011.07.014 doi
Advisory Committees
Area Under Curve
Canada
Delayed-Action Preparations--pharmacokinetics
Drug Approval--legislation & jurisprudence
Drugs, Generic--pharmacokinetics
Government Regulation
Humans
Therapeutic Equivalency
United States
United States Food and Drug Administration
The need for additional metrics to assess therapeutic equivalence of some multiphasic modified-release products. [electronic resource] - Clinical therapeutics Sep 2011 - 1214-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1879-114X
10.1016/j.clinthera.2011.07.014 doi
Advisory Committees
Area Under Curve
Canada
Delayed-Action Preparations--pharmacokinetics
Drug Approval--legislation & jurisprudence
Drugs, Generic--pharmacokinetics
Government Regulation
Humans
Therapeutic Equivalency
United States
United States Food and Drug Administration